SE

Sagian Equity

North America, Indiana, United States, Zionsville

Description

Sagian Equity is a private investment firm.

Investor Profile

Sagian Equity has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series D rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Health Diagnostics.

Stage Focus

  • Series C (50%)
  • Series D (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sagian Equity frequently co-invest with?

FusionX Ventures
North America, California, United States, San Diego
Co-Investments: 2
Vertical Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 2
Casdin Capital
North America, New York, United States, New York
Co-Investments: 1
Warburg Pincus
Europe, Madrid, Spain, Boadilla Del Monte
Co-Investments: 1
Yonjin Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Illumina Ventures
North America, California, United States, Foster City
Co-Investments: 2
AV
North America, California, United States, Palo Alto
Co-Investments: 1
Anzu Partners
North America, District of Columbia, United States, Washington
Co-Investments: 1

What are some of recent deals done by Sagian Equity?

NanoCellect Biomedical

San Diego, California, United States

NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series DAug 13, 2021
Amount Raised: $20,000,000
NanoCellect Biomedical

San Diego, California, United States

NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series CFeb 1, 2021
Amount Raised: $15,000,000